Gene · 708
Papers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of novel mutations among Iranian NPC1 patients: a bioinformatics approach to predict pathogenic mutations. | Hereditas | 2022 | 35086560 | PubTator, text mining | PubMed |
| Porcine circovirus type 2 infection inhibits the activation of type I interferon signaling via capsid protein and host gC1qR. | Vet Microbiol | 2022 | 35085949 | PubTator, text mining | PubMed |
| Strategies to Improve Photodynamic Therapy Efficacy of Metal-Free Semiconducting Conjugated Polymers. | Int J Nanomedicine | 2022 | 35082494 | PubTator, text mining | PubMed |
| Porcine TRIM21 Enhances Porcine Circovirus 2 Infection and Host Immune Responses, But Inhibits Apoptosis of PCV2-Infected Cells. | Viruses | 2022 | 35062360 | PubTator, text mining | PubMed |
| Exosomes: the key of sophisticated cell-cell communication and targeted metastasis in pancreatic cancer. | Cell Commun Signal | 2022 | 35033111 | PubTator, text mining | PubMed |
| Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. | J Exp Med | 2022 | 35029648 | PubTator, text mining | PubMed |
| Metabolic adaptation of lymphocytes in immunity and disease. | Immunity | 2022 | 35021054 | PubTator, text mining | PubMed |
| EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation. | Nat Commun | 2022 | 35013218 | PubTator, text mining | PubMed |
| Predicting the targets of IRF8 and NFATc1 during osteoclast differentiation using the machine learning method framework cTAP. | BMC Genomics | 2022 | 34991467 | PubTator, text mining | PubMed |
| Co-circulation and evolution of genogroups I and II of respiratory and enteric feline calicivirus isolates in cats. | Transbound Emerg Dis | 2022 | 34982847 | PubTator, text mining | PubMed |
| Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. | Cell Commun Signal | 2022 | 34980146 | PubTator, text mining | PubMed |
| Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune function. | Cancer Sci | 2022 | 34978120 | PubTator, text mining | PubMed |
| UBE2O and USP7 co-regulate RECQL4 ubiquitinylation and homologous recombination-mediated DNA repair. | FASEB J | 2022 | 34921745 | PubTator, text mining | PubMed |
| Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir. | Intern Med | 2022 | 34897154 | PubTator, text mining | PubMed |
| HABP1 promotes proliferation and invasion of lung adenocarcinoma cells through NFκB pathway. | Neoplasma | 2022 | 34881631 | PubTator, text mining | PubMed |
| Biogenesis of hepatitis B virus e antigen is driven by translocon-associated protein complex and regulated by conserved cysteine residues within its signal peptide sequence. | FEBS J | 2022 | 34839586 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| The role of complement in the clinical course of hepatocellular carcinoma. | Immun Inflamm Dis | 2022 | 34813686 | PubTator, text mining | PubMed |
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. | J Allergy Clin Immunol | 2022 | 34800432 | PubTator, text mining | PubMed |
| Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation. | Nat Rev Immunol | 2022 | 34759348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/papers?page=24